Carisma Therapeutics Inc. (CARM)
Company Info
Highlights
$20.03M
-$1.52
$15.98M
$14.03M
-$41.64M
$0.38 - $2.77
$6.50
2.13%
1.34
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Carisma Therapeutics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Carisma Therapeutics Inc. had a return of 14.57% year-to-date (YTD) and -80.09% in the last 12 months. Over the past 10 years, Carisma Therapeutics Inc. had an annualized return of -44.93%, while the S&P 500 had an annualized return of 11.31%, indicating that Carisma Therapeutics Inc. did not perform as well as the benchmark.
CARM
14.57%
8.87%
-61.62%
-80.09%
-49.55%
-44.93%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of CARM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 9.79% | 14.57% | |||||||||||
| 2024 | -28.33% | 22.86% | -12.02% | -28.19% | -18.40% | 14.29% | -29.61% | -0.00% | -8.26% | -0.83% | -12.25% | -50.97% | -85.71% |
| 2023 | 1.44% | -6.19% | -68.58% | 33.87% | 36.63% | 54.67% | -36.72% | 24.68% | -38.87% | -29.08% | -20.00% | 22.08% | -71.74% |
| 2022 | -9.09% | -14.39% | -4.98% | -36.93% | 61.25% | 32.22% | -3.13% | -12.10% | -38.41% | 31.34% | -0.79% | 10.06% | -25.21% |
| 2021 | 26.67% | 59.06% | -4.41% | 10.77% | 16.32% | 37.91% | -19.26% | -74.59% | -16.32% | 52.55% | -13.22% | -22.38% | -39.63% |
| 2020 | -8.66% | -19.99% | -26.24% | -1.93% | 46.27% | -10.47% | 44.44% | -0.96% | 35.92% | -27.14% | 21.57% | 8.87% | 29.81% |
| 2019 | -48.66% | 30.31% | 8.42% | 20.39% | 79.03% | -32.43% | -18.00% | -11.38% | 7.34% | 4.27% | -3.28% | -11.86% | -26.76% |
| 2018 | 28.24% | -8.65% | 10.53% | 165.71% | -18.64% | -14.10% | -10.26% | 28.00% | -4.02% | -31.16% | 16.89% | -17.92% | 75.09% |
| 2017 | 12.04% | -6.54% | 10.00% | -13.64% | -27.89% | 14.60% | -6.43% | -26.49% | 46.30% | -39.87% | -30.53% | 22.88% | -57.54% |
| 2016 | -89.36% | -7.93% | 8.14% | 172.07% | 42.87% | 34.68% | 137.72% | 22.92% | -42.62% | -37.14% | 27.27% | -14.73% | -36.54% |
| 2015 | -2.36% | -8.88% | -15.61% | 32.74% | -76.27% | 0.36% | -1.77% | 27.44% | -31.73% | 11.62% | 18.59% | -5.64% | -74.66% |
| 2014 | 49.31% | 0.19% | -16.88% | -19.94% | 22.04% | -16.77% | 1.00% | 0.54% | -5.21% | 7.77% | 4.39% | 9.49% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CARM is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Carisma Therapeutics Inc. (CARM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Carisma Therapeutics Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 |
|---|---|---|---|
| Dividend | $0.00 | $0.00 | $1.90 |
Dividend yield | 0.00% | 0.00% | 64.70% |
Monthly Dividends
The table displays the monthly dividend distributions for Carisma Therapeutics Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | ||||||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $1.90 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.90 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Carisma Therapeutics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Carisma Therapeutics Inc. was 99.87%, occurring on Dec 23, 2024. The portfolio has not yet recovered.
The current Carisma Therapeutics Inc. drawdown is 99.84%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.87% | Feb 28, 2014 | 2724 | Dec 23, 2024 | — | — | — |
| -1.65% | Feb 14, 2014 | 1 | Feb 14, 2014 | 1 | Feb 18, 2014 | 2 |
| -0.17% | Feb 12, 2014 | 1 | Feb 12, 2014 | 1 | Feb 13, 2014 | 2 |
Volatility
Volatility Chart
The current Carisma Therapeutics Inc. volatility is 25.81%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Carisma Therapeutics Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |